Bangladesh vs El Salvador: Immunization, measles
Bangladesh
96.0%
in 2024
El Salvador
96.0%
in 2024
Bangladesh rank
46th
El Salvador rank
46th
Immunization, measles over time
- Bangladesh
- El Salvador
How they compare
Bangladesh currently reports 96.0% against 96.0% in El Salvador, a difference of 0.0%.
The two have swapped places 10 times across 43 shared years of data; in 1982 it was El Salvador ahead.
Bangladesh ranks 46th and El Salvador ranks 46th of 193 countries.
Across the 5 decades both report, Bangladesh averaged higher in 2 and El Salvador in 3.
Head to head by decade
| Decade | Bangladesh | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 9.9% | 54.5% | 44.6% | El Salvador |
| 1990s | 71.6% | 85.1% | 13.5% | El Salvador |
| 2000s | 82.8% | 95.0% | 12.2% | El Salvador |
| 2010s | 93.9% | 93.1% | 0.8% | Bangladesh |
| 2020s | 96.4% | 91.2% | 5.2% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Bangladesh or El Salvador?
- Bangladesh, at 96.0% against 96.0% in El Salvador as of 2024.
- What is the difference in immunization, measles between Bangladesh and El Salvador?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and El Salvador?
- 43 years are reported by both, from 1982 to 2024.
- How do Bangladesh and El Salvador rank globally for immunization, measles?
- Bangladesh ranks 46th and El Salvador ranks 46th of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.